NationalOver 1.20 Crore Covid Vaccine Doses Were Supplied To Private Hospitals: CentreBY Outlook Web Bureau
NationalWhy Start Vaccine Centres With ‘Pomp And Splendour’ If 2nd Dose Of Covaxin Not Available: HC To Delhi GovtBY Outlook Web Bureau
NationalVillagers Get Mixed Shots Of Covaxin And Covishield In UP's Govt Hospital; CMO Says 'Definitely An Oversight'BY Outlook Web Bureau
NationalAmid Travel Fears, Bharat Biotech Says Expecting WHO Nod For Covaxin in July- SeptemberBY Outlook Web Bureau
NationalMore Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHOBY Outlook Web Bureau
NationalDo Kids Need Covid Vaccines, What Are The Side Effects And Precautions, Know From ExpertBY Dr. Prabhat Maheshwari
NationalCovaxin Effective Against UK Strain And Covid Variant Found In India: Bharat BiotechBY Outlook Web Bureau
NationalCovid Explained: How Phase 2 And 3 Trials For Covaxin On Kids Will Be Conducted?BY Outlook Web Bureau
NationalWhat Makes Some Vaccinated People More Susceptible To Covid-19 Than Others? Experts AnswerBY Dr. Harshal R Salve and Dr. Sachin Jain
NationalBharat Biotech Says Can’t Give Additional Covaxin Doses to Delhi: Manish SisodiaBY Outlook Web Bureau
NationalExperts Recommend Bharat Biotech’s Covaxin For Phase 2/3 Trials On 2-18-Year-OldsBY Outlook Web Bureau
NationalDelhi’s Covaxin Stock Will Run Out In A Day, Covishield Doses Will Last 3-4 Days: Satyendar JainBY Outlook Web Bureau
Making A DifferenceCan Covaxin Neutralise 617 Variant Of Covid? Know It From Dr Anthony FauciBY Outlook Web Bureau
NationalCovishield, Covaxin Offer Protection Against 'Indian Strain' Of Coronavirus, Says StudyBY Outlook Web Bureau
NationalBharat Biotech’s Covaxin To Cost Rs 1200 For Private Hospitals, Rs 600 For State GovtsBY Outlook Web Bureau
National21,000 People Contracted Covid-19 After Receiving First Dose Of Vaccine: CentreBY Outlook Web Bureau
NationalCovaxin Is 78% Effective Against Mild To Severe Covid-19 Infections: Bharat BiotechBY Outlook Web Bureau
NationalBharat Biotech’s Covaxin Neutralises Multiple Coronavirus Variants: ICMRBY Outlook Web Bureau